当前位置: X-MOL 学术BJU Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?
BJU International ( IF 3.7 ) Pub Date : 2024-11-08 , DOI: 10.1111/bju.16584
Tivya Kulasegaran, Niara Oliveira, Craig Gedye, Shomik Sengupta

Click on the article title to read more.

中文翻译:


高危肾细胞癌的辅助免疫治疗——现在还是永远?



点击文章标题阅读更多内容。
更新日期:2024-11-08
down
wechat
bug